From: The presence of SARS-CoV-2 in multiple clinical specimens of a fatal case of COVID-19: a case report
Reference range | Upon admission | 5th day | 10th day | 13th day | 19th day | |
---|---|---|---|---|---|---|
Leukocytes (µL) | 4.0–9.0 × 103 | 6.88 | – | 11.00 | 11.56 | 14.96 |
Red blood cells (µL) | 4.0–5.5 × 103 | 2.94 | – | 3.04 | 3.12 | 3.22 |
Hemoglobin (g/dL) | 13.0–16.5 × 103 | 9.10 | – | 8.90 | 9.10 | 10.60 |
Hematocrit (%) | 40–48 | 31.40 | – | 28.30 | 29.20 | 33.50 |
Platelets (µL) | 150–400 × 103 | 102.00 | – | 195.00 | 256.00 | 244.00 |
Neutrophils (µL) | 2.0–7.0 × 103 | 6.13 | – | 10.53 | 10.86 | 14.71 |
Banded Neutrophils (%) | 1–6 | – | – | 14 | 6 | 46 |
Segmented Neutrophils (%) | 40–72 | – | – | 79 | 88 | 47 |
Lymphocytes (µL) | 1.2–3.5 × 103 | 0.23 | – | 0.12 | 0.11 | 0.06 |
Monocytes (µL) | 0.2–0.8 × 103 | 0.30 | – | 0.32 | 0.56 | 0.16 |
Eosinophils (µL) | 0.04–0.5 × 103 | 0.03 | – | 0 | 0 | 0 |
PCT (ng/mL) | 0.00–0.05 | 0.61 | 0.24 | – | – | – |
ALAT (U/L) | < 41 | 17.07 | 25.00 | – | – | 10.00 |
ASAT (U/L) | < 40 | 35.91 | – | – | – | – |
GGT (U/L) | < 61 | – | 111.00 | – | – | – |
Bilirubin (µmol/L) | < 21 | 13.51 | – | – | – | – |
Potassium (mmol/L) | 3.5–5.1 | 3.51 | 4.75 | – | – | 3.93 |
Sodium (mmol/L) | 136–146 | 130.31 | 137.50 | – | – | 141.50 |
Creatinine (µmol/L) | 62–106 | 88.26 | 70.00 | – | – | 125.00 |
GFR (MDRD, mL/min) | > 90 | 75.92 | 100.00 | – | – | 51.00 |
CRP (mg/L) | < 5 | 166.70 | 41.70 | 177.00 | 50.00 | 239.30 |
D-dimer (μg/mL) | < 0.5 | 1.44 | 1.45 | – | – | – |
IL-6 (pg/mL) | 0.0–3.4 | – | 93.00 | – | – | – |
Troponin T (pg/mL) | < 50 | 89.03 | – | – | – | – |
HIV test | – | NEG | – | – | – |